New CRISPR test could speed up sepsis diagnosis and save lives
NCT ID NCT07580001
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test a new rapid test called NuRapid-CRISPR that uses CRISPR technology to quickly find the germ causing sepsis in ICU patients. The goal is to see if using this test helps doctors choose the right antibiotics faster and reduces deaths within 28 days. About 396 adults with suspected sepsis will take part across multiple hospitals.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- NuRapid-CRISPR rapid pathogen detection test
- What this could lead to
- If successful, this test could help doctors identify the cause of sepsis faster and choose the right antibiotics sooner, potentially saving lives in the ICU.
- What could go wrong
- This is an early-stage study that hasn't started recruiting yet. The test may not prove faster or more accurate than current methods, and results may not apply to all hospitals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Center for Critical Care Medicine, Tongji Hospital, Shanghai
Shanghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shanghai Dongfang Hospital
Shanghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Yangpu District Central Hospital, Shanghai
Shanghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a key hormone be missing in septic shock?
- Sweat sensor could replace blood draws for sepsis monitoring
- Could a simple mineral cut the need for powerful blood-pressure drugs in septic shock?
- Blood filter aims to calm deadly inflammation in septic shock
- Experts unite to define sepsis care standards for Sub-Saharan africa
- Could a 45-Minute talk after sepsis stop PTSD before it starts?